Advertisement
TECA Corporation
TECA Corporation

News Analysis

Most Recent

110m into post-genomic research

By | November 22, 2000

500,000 people will help research councils to solve post-genomic puzzles.

0 Comments

Children's parents sue hospital over genetics patent

By | November 22, 2000

Families of children suffering a degenerative brain disease are suing the hospital and researchers who used their children's blood and tissue to identify and patent the gene responsible for the disorder.

0 Comments

Italy: a GMO-free country?

By | November 21, 2000

The Italian Minister for Agricultural and Forestry Policy has made it clear he intends to ban GMOs of agricultural interest - but will he manage to sway the Italian public?

0 Comments

HOUSTON "Mosquitoes are flying syringes," declared Frank Cortez-Flores of Loma Linda University (California), and two mosquito-borne diseases have broken past old geographic boundaries to invade the US. The first, West Nile encephalitis, is a newcomer to the western hemisphere and thus has garnered the most headlines. The other, dengue fever, is considered the world's most important vector-borne viral disease affecting people, in terms of both morbidity and mortality. The West Nile virus, native

0 Comments

Nice and open

By | November 20, 2000

The UK's National Institute for Clinical Excellence has opted to remove confidentiality from its appraisal process as a means of pre-empting information leaks.

0 Comments

Patent knowledge

By | November 20, 2000

A special report just published in the UK reveals the extent and pace of the gene patent rush.

0 Comments

Nearly a million children die each year of malaria, but the parasite became resistant to the cheapest drug. Now we know why.

0 Comments

Modifying genetic research

By | November 15, 2000

GM food has provoked much protest but GM medicine has more public approval: the difference lies in approaches to research.

0 Comments

Many drugs effective against tropical diseases are no longer available or in danger of being pulled from the market because they are unprofitable.

0 Comments

Ritalin gets vote of approval in the UK

By | November 9, 2000

A new UK directive supports use of the controversial drug Ritalin in severe Attention Deficit/Hyperactivity Disorder (ADHD), but only under specialist supervision.

0 Comments

Advertisement

Popular Now

  1. Antibiotics and the Gut Microbiome
  2. Sex Differences in Pain Pathway
  3. The Sum of Our Parts
    Features The Sum of Our Parts

    Putting the microbiome front and center in health care, in preventive strategies, and in health-risk assessments could stem the epidemic of noncommunicable diseases.

  4. Anti-Vax Doctor Found Dead
    The Nutshell Anti-Vax Doctor Found Dead

    Police are calling the death of James Bradstreet, a physician who claimed vaccines cause autism and offered autism cures to patients, an apparent suicide.

Advertisement
The Scientist